Remarkably different results between two studies from North America on genomic mutations and sensitivity to DNA demethylating agents for myelodysplastic syndromes.
Chin J Cancer Res
; 29(6): 587-588, 2017 Dec.
Article
em En
| MEDLINE
| ID: mdl-29353982
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Diagnostic_studies
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article